Dr. Simon Tucker serves as Vice President of Research at Biota Holdings Ltd. He joined the Company in 1997. He has over 20 years of scientific and commercial experience in research and development. Prior to joining the Company, he held leadership positions at GD Searle and Universities of Alabama, the United States and Glasgow, the United Kingdom. He has experience in biotechnology and pharmaceutical research and development, intellectual property management, research and development alliance management, licensing and related areas.
VP of Research
The company has return on total asset (ROA) of (15.95) % which means that it has lost $15.95 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (27.83) % meaning that it generated substantial loss on money invested by shareholders.
Entity SummaryBiota Holdings Limited engages in the drug discovery and clinical development of antiinfectives in Australia. Biota Pharmaceuticals Inc [BTA] is traded on Australian Securities Exchange in Australia. It is located in Notting Hill, VIC and employs 15 people. Filter other
|Click to run this filter|| |
Filter Other Insiders
| BTA Australian #AU000000BTA1AU
Biota Pharmaceuticals Inc
Benchmark S&P 500
Currency: AUD - Australian Dollar
Traded on Australian Securities Exchange
Biota Pharmaceuticals Inc has more than 78.4 (%) percent chance of experiencing financial distress in the next 2 years of operations.
Promote Biota and Simon Tucker